Accessibility
Hamilton Health Sciences
News Releases
Print
 Print this page Print

HHS
Extension of Murray Martin’s Term as President and CEO
The Board of Directors of Hamilton Health Sciences has asked Murray Martin to remain as President & CEO for an additional year and he has accepted. Mr. Martin was scheduled to retire as President and CEO on Dec. 31, 2012. He will now be in the role until Jan. 31, 2014, and will then serve as Special Advisor to the Board for three months, from Feb. 1 to April 30, 2014, during the transition to his replacement.

“Our organization will benefit directly from another year of Murray’s experience and leadership,” said Mark Rizzo, Chair of the Board of Directors. “We believe that it is vital to have experience and continuity in the CEO role during this time of change and challenge in health care in Ontario.”

The Ministry of Health and Long-Term Care has signaled that it expects all healthcare providers to participate in identifying and developing new and better approaches to healthcare delivery. There are many opportunities for system-wide innovation and that is a key strength of Mr. Martin, as well as a key feature of his years of experience, Mr. Rizzo said.

The Board will be asking Mr. Murray to seek opportunities for further system integration, complete HHS’ strategic planning process that is now well underway, and put in place a new organization structure to fill the void that will be left at the end of May with the departure of Murray Glendining, Executive Vice-President Corporate Affairs, to London Health Sciences.
Hamilton Health Sciences • Hamilton, Ontario • 905.521.2100

Disclaimer: Hamilton Health Sciences (HHS) offers Google Translate to better facilitate access for our community. However, HHS makes no claims regarding the accuracy of translations. Any and all health information should be verified by a health care professional.